Navigation Links
Dow Agrosciences licenses exclusive novel crop enhancement technology
Date:11/2/2010

The John Innes Centre is pleased to announce an exclusive commercial license agreement for technology that enhances the root systems of plants and with important implications for crop improvement. JIC's technology management company Plant Bioscience Limited (PBL) is licensing the technology to Dow AgroSciences.

Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), entered into an exclusive commercial license agreement with Plant Bioscience Limited (PBL) for technology that enhances the root systems of plants with important implications for crop improvement. The commercial license covers a range of important agricultural crops.

The technology was developed by Dr. Liam Dolan and his colleagues at the John Innes Centre, an institute of the BBSRC on the Norwich Research Park. With BBSRC funding, the team cloned and characterized genes which may play vital roles in anchorage, water use and nutrient uptake in plants. The genes are highly conserved among land plants and the technology has already been shown to be effective in enhancing root systems in transgenic plants of major crops around the world.

"Our research aims to answer key questions in biology and to provide solutions to important problems in food security, energy production, promoting health and combating disease," said Professor Dale Sanders, Director of the John Innes Centre. "The technology was born out of basic research in nutrient uptake by plants and demonstrates the importance to agriculture of answering fundamental questions."

"Dow AgroSciences is excited to be collaborating with one of the most respected organizations in the biotechnology industry," said Dan Kittle, Ph.D., vice president of Dow AgroSciences. "By combining our expertise in biotech crops and PBL's innovative technology from JIC, we have the opportunity to enhance a plant's ability to survive stress, increase nutrient utilization, and provide yield stability in challenging years or
'/>"/>

Contact: Zoe Dunford
zoe.dunford@bbsrc.ac.uk
44-016-032-55111
Norwich BioScience Institutes
Source:Eurekalert

Page: 1 2

Related biology news :

1. Ocera Therapeutics licenses novel treatment for acute hepatic encephalopathy from UCLB
2. UGA licenses invention that kills food-borne pathogens in minutes
3. UGA licenses new Bermuda grass that thrives in sun and shade
4. UGA licenses technology to make fuel from dead forests and agricultural waste
5. MSU licenses plant oil enhancement technology to BASF Plant Science
6. TAXIS Pharmaceuticals licenses novel antimicrobial technology from Rutgers and UMDNJ
7. UT-Battelle licenses tissue regeneration technologies to NellOne Therapeutics, Inc.
8. Virginia Tech licenses GenoCAD source code to ISCB
9. UC Riverside licenses technology to OlFactor Laboratories, Inc.
10. U of M licenses unique plant protection product
11. Brown licenses potential muscular dystrophy treatment to Tivorsan Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... French . ... with Alzheimer,s disease can be reversed with treatment. The study ... The Neuro, at McGill University and at Universit de Montral ... the brain of mice with advanced Alzheimer,s disease (AD) recovers ... Journal of Neuroinflammation in May, also suggest an underlying ...
(Date:6/16/2013)... cells use to group together and move around the body ... the first time by scientists at UCL. , Published ... on the process that occurs when cancer cells interact with ... metastasis. Scientists know that cancer cells recruit healthy cells and ... takes place and how it could be controlled to design ...
(Date:6/14/2013)... understanding and explaining how evolution operates. In search ... at Michigan State University developed complete evolutionary case ... underlying an evolving characteristic to their genetic consequences ... T. White, Merle K. Heidemann, and James J. ... a cellular and molecular biology course taught to ...
Breaking Biology News(10 mins):Blocking overactive receptor in Alzheimer's recovers memory loss and more 2'Chase and run' cell movement mechanism explains process of metastasis 2Teaching complete evolutionary stories increases learning 2
... Cancerous tumors are wildly unfavorable environments. Struggling ... the bodys defense systems, tumor cells in fact ... decades, scientists have sought ways to circumvent these ... University of Massachusetts Medical School (UMMS), have defined ...
... - BioMed Central today announced the launch of Biology ... over 11,000 carefully selected biology-related images. This is ... Science Navigation Group of companies which was also responsible ... resource. The Library is a new subscription-based service ...
... public health issue and economic problem has been ... the University Denis Diderot in Paris, and the ... chlorine-resistant parasites, known as Cryptosporidium, which cause a ... significant mortality in immunodeficient patients, become virtually inactive ...
Cached Biology News:Sidestepping cancer's chaperone 2Ultraviolet light helps to secure water supply 2
(Date:6/18/2013)... 2013 Demanding industrial and environmental conditions ... synthetic Sapphire and Glass Ball Lenses, now available in ... Jewel Company , of Philadelphia , PA. , Optical ... the light beams without the need for direct physical ... durability (9 mohs) make it the ideal choice for ...
(Date:6/18/2013)... RegeneCure announced today the start of a ... (GBR) Dental Membrane as a bone stimulating aid for patients ... patients have a tooth replaced with a dental implant is ... Consequently there is often a need to support the implant ... bone substitute material, in turn, needs to be held in ...
(Date:6/18/2013)... , June 18, 2013  AMRI (NASDAQ: ... Burlington, Mass. , site has ... Enforcement Administration (DEA) registration to handle Schedule 2 ... DEA,s acknowledgement of Burlington,s ... and documentation. (Logo: http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) ...
(Date:6/18/2013)... 18, 2013 This webinar will ... advertising and promotion, and review the basic FDA ... how to apply these principles through real world ... ,     The fundamentals on FDA regulations and guidance ... ,     Assessing traditional and newer forms of ...
Breaking Biology Technology:Swiss Jewel Introduces the Crown Jewels of Fiber-Optic Connectors 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2
... S.A., a,French drug and diagnostic discovery company, today announces ... 2007., 2007 Key Events, - Milestone reached ... AGN ) in view of the initiation of Phase ... - Approval by the AFSSAPS (Agence Francaise de ...
... Germany, March 5 In mid-March the German,Bundestag (Lower ... the German Stem,Cell Act. The opposing poles in the ... apart: its proponents are calling for the complete,liberalisation of ... of a,general ban on the use of human stem ...
... Statins Alone, in Decreasing Cardiovascular Events in Diabetics with Haptoglobin ... ... March 5 Synvista,Therapeutics, Inc. (Amex: SYI ) announces the publication ... E to statin therapy prevented more cardiovascular events (heart,attack, stroke and cardiovascular ...
Cached Biology Technology:ExonHit Therapeutics - 2007 Financial Results 2ExonHit Therapeutics - 2007 Financial Results 3ExonHit Therapeutics - 2007 Financial Results 4ExonHit Therapeutics - 2007 Financial Results 5ExonHit Therapeutics - 2007 Financial Results 6ExonHit Therapeutics - 2007 Financial Results 7ExonHit Therapeutics - 2007 Financial Results 8ExonHit Therapeutics - 2007 Financial Results 9ExonHit Therapeutics - 2007 Financial Results 10ExonHit Therapeutics - 2007 Financial Results 11ExonHit Therapeutics - 2007 Financial Results 12A New Era in Cell Biology: German Company Develops Groundbreaking Alternative to Stem Cell Therapy 2A New Era in Cell Biology: German Company Develops Groundbreaking Alternative to Stem Cell Therapy 3Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes 2Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes 3Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes 4
... 384 is a compact and self-contained ... is a unique flow-through device, which ... included wash system. Optional refill ... system. Will be upgradable to ...
This kit is designed to select cells labeled with phycoerythrin- (PE-) conjugated antibodies. Kit includes reagents for labeling 3 x 10 9 cells and EasySep magnet....
... Caliper's iLink makes it easy to ... laboratory instruments. Developed with operator convenience in ... and shoot' ease of use. The iLink ... workstations for assays or sub-assays, that can ...
... meet your laboratory's requirements for data management and quality control. ... ... ... the standard software for Staccato Systems and custom Allegro Modules allowing for the simple interface with ...
Biology Products: